Genelux Corp Share Price: GNLX (Genelux Corp) Stock Price Today & Updates | INDmoney

Question 1

What is Genelux Corp share price today?

Accepted Answer

Genelux Corp (GNLX) share price today is {{live_price}}.

Question 2

Can Indians buy Genelux Corp shares?

Accepted Answer

Yes, Indians can invest in the Genelux Corp (GNLX) from India.

With INDmoney, you can buy Genelux Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Genelux Corp at zero transaction cost.

Question 3

How can I buy Genelux Corp shares from India?

Accepted Answer

It is very easy to buy Genelux Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Genelux Corp be purchased?

Accepted Answer

Yes, you can buy fractional shares of Genelux Corp with INDmoney app.

Question 5

What are the documents required to start investing in Genelux Corp stocks?

Accepted Answer

To start investing in Genelux Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Genelux Corp

Accepted Answer

Today’s highest price of Genelux Corp (GNLX) is {{1_rba_end}}.

Today’s lowest price of Genelux Corp (GNLX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Genelux Corp

Accepted Answer

Today's market capitalisation of Genelux Corp GNLX is 97.0M

Question 8

What is the 52 Week High and Low Range of Genelux Corp

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Genelux Corp is down from its 52 Week High?

Accepted Answer

Genelux Corp (GNLX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Genelux Corp is up from its 52 Week low?

Accepted Answer

Genelux Corp (GNLX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Genelux Corp?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Genelux Corp

Accepted Answer

Mr. Thomas  Zindrick J.D. is the current Chief Executive Officer (CEO) of Genelux Corp.

Period	Genelux Corp	Index (Russel 2000)
3 Months	25.57%	0.0%
6 Months	-17.91%	0.0%
1 Year	-85.84%	0.0%
3 Years	-55.28%	-23.0%

Market Capitalization	97.0M
Book Value	$1.11
Earnings Per Share (EPS)	-0.95
Wall Street Target Price	21.5

Profit Margin	0.0%
Operating Margin TTM	-341437.5%

Return On Assets TTM	-44.61%
Return On Equity TTM	-88.57%

Revenue TTM	8.0K
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	-95.3%
Gross Profit TTM	11.1M
EBITDA	-27.0M
Diluted Eps TTM	-0.95
Quarterly Earnings Growth YOY	0.0

Genelux Corp (GNLX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Decreasing Revenue

Increasing Net Profit

Vs ALNY

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.85
EPS Estimate Next Year	-0.93
EPS Estimate Current Quarter	-0.19
EPS Estimate Next Quarter	-0.18

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Genelux Corp	27.91%	-17.91%	-85.84%	-55.28%	-55.28%
Regeneron Pharmaceuticals, Inc.	-9.28%	10.06%	24.53%	74.0%	232.45%
Novo Nordisk A/s	-4.54%	-5.72%	21.59%	126.2%	349.01%
Alnylam Pharmaceuticals, Inc.	8.87%	102.98%	82.67%	44.83%	241.09%
Vertex Pharmaceuticals Incorporated	5.0%	20.77%	31.37%	158.16%	163.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Genelux Corp	NA	NA	NA	-0.85	-0.89	-0.45	NA	1.11
Regeneron Pharmaceuticals, Inc.	26.41	26.41	1.37	44.9	0.17	0.08	NA	261.41
Novo Nordisk A/s	40.21	40.21	1.81	3.36	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.42	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.59	0.18	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Genelux Corp	Buy	$97.0M	-55.28%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$110.0B	232.45%	26.41	32.04%
Novo Nordisk A/s	Buy	$529.8B	349.01%	40.21	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$38.1B	241.09%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$128.7B	163.17%	32.84	-4.74%

Organization	Genelux Corp
Employees	24
CEO	Mr. Thomas Zindrick J.D.
Industry	Miscellaneous